Subscribe To
Bristow group inc. (vtol) q3 2023 earnings call transcript
Bristow Group Inc. (NYSE:VTOL ) Q3 2023 Earnings Call November 2, 2023 10:00 AM ET Company Participants Red Tilahun - Investor Relations Christopher B...
November 4, 2023, 8:07 am
Prime medicine reports third quarter 2023 financial results and provides business updates
— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...
November 3, 2023, 8:01 pm
Kineta reports third quarter 2023 financial results and provides corporate update
Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first patient of KVA12123 in comb...
November 3, 2023, 8:01 pm
Ventas, inc. (vtr) q3 2023 earnings call transcript
Ventas, Inc. (NYSE:VTR ) Q3 2023 Earnings Conference Call November 3, 2023 10:00 AM ET Company Participants BJ Grant - SVP, IR Debra Cafaro - Chairman...
November 3, 2023, 1:41 pm
Ovid therapeutics reports third quarter 2023 financial results and corporate updates
Received a $30 million payment from Ligand for the sale of a 13% interest in the potential future royalties and milestone payments owed to Ovid for so...
November 3, 2023, 12:00 pm
Plains all american reports third-quarter 2023 results & raises 2023 guidance
Announces Capital Allocation Updates & Permian Bolt-On Acquisitions HOUSTON, Nov. 03, 2023 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Na...
November 3, 2023, 11:30 am
Rapid micro biosystems reports third quarter 2023 financial results
reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third ...
November 3, 2023, 11:00 am
Shenandoah telecommunications company reports third quarter 2023 results
EDINBURG, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel”) (Nasdaq: SHEN) announced third quarter 2023 fi...
November 3, 2023, 11:00 am
Vital energy reports third-quarter 2023 financial and operating results
Record quarterly production exceeds guidance, leads to increased full-year 2023 outlook Capital investments in quarter were below guidance Publishes 2...
November 2, 2023, 8:25 pm
Nl reports third quarter 2023 results
Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss attributable to NL stockholders of $.1 mill...
November 2, 2023, 8:20 pm
Stryker reports third quarter 2023 operating results
Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Res...
November 2, 2023, 8:17 pm
Cidara therapeutics provides corporate update and reports third quarter 2023 financial results
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing targeted therapi...
November 2, 2023, 8:15 pm
Intra-cellular therapies reports third quarter 2023 financial results and raises 2023 caplyta sales guidance
Q3 2023 total revenues increased to $126.2 million, compared to $71.9 million in the same period in 2022 CAPLYTA Q3 2023 net product sales were $125.8...
November 2, 2023, 11:30 am
Autolus therapeutics reports third quarter 2023 financial results and business updates
Obe-cel, a potentially transformational treatment for relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL), on track for a Biolog...
November 2, 2023, 11:11 am
Biocryst reports third quarter 2023 financial results and provides business update
– Q3 2023 ORLADEYO net revenue of $85.7 million (+29.8 percent y-o-y) — – Company expects to achieve no less than $320 million in full year 2023...
November 2, 2023, 11:00 am
Teleflex reports third quarter financial results and full year 2023 outlook
WAYNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third q...
November 2, 2023, 10:30 am
Springworks therapeutics reports third quarter 2023 financial results and recent business highlights
– PDUFA target action date for nirogacestat NDA in adults with desmoid tumors remains set for November 27, 2023 – – On track to report topline d...
November 2, 2023, 10:30 am
Regeneron reports third quarter 2023 financial and operating results
Third quarter 2023 revenues increased 15% to $3.36 billion versus third quarter 2022 Third quarter 2023 Dupixent® global net sales (recorded by Sanof...
November 2, 2023, 10:30 am
Landsea homes reports third quarter 2023 results
Third Quarter 2023 Highlights Net income attributable to Landsea Homes of $8.6 million, or $0.22 per diluted share Pretax income of $12.5 million Tota...
November 2, 2023, 10:00 am
Microstrategy q3 earnings highlights: revenue beat, bitcoin holdings update and average cost per btc
MicroStrategy reports third-quarter revenue of $129.5 million, which was up 3% year-over-year. The comp...
November 1, 2023, 9:44 pm